MOONSTONE/GOG-3032: Interim Analysis of a Phase 2 Study of Niraparib + Dostarlimab in Patients (pts) with Platinum-Resistant Ovarian Cancer (PROC).
Leslie M. Randall,David M. O'Malley,Bradley J. Monk,Robert L. Coleman,Stephanie Gaillard,Sarah F. Adams,Linda R. Duska,Fabio Cappuccini,Heather Dalton,Robert W. Holloway,Marilyn Huang,Hye Sook Chon,Noelle Gillette Cloven,Adam ElNaggar,Roisin Eilish O'Cearbhaill,Steven E. Waggoner,Zebin Wang,Eric Zhi,Vivek Samnotra,Panagiotis A. Konstantinopoulos JOURNAL OF CLINICAL ONCOLOGY（2022）
AI 理解论文
溯源树
样例
